Brief: Annexin Resolves On Rights Issue Of SEK 45.1 Mln

Annexin Pharmaceuticals AB (publ)

28/03/2024 08:16

March 28 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * RESOLVES ON A RIGHTS ISSUE OF SEK 45.1 MILLION GUARANTEED
TO 90
PERCENT, SUBJECT TO APPROVAL BY THE 2024 ANNUAL GENERAL MEETING,
WHICH HAS BEEN DECIDED TO BE BROUGHT FORWARD
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE AMOUNTS TO SEK 0.25 PER
NEW
SHARE
    * SUBSCRIPTION PERIOD IN RIGHTS ISSUE WILL RUN FROM 14 MAY
2024 UP
TO AND INCLUDING 28 MAY 2024
    * PROCEEDS FROM RIGHTS ISSUE WILL BE USED TO STRENGTHEN
WORKING
CAPITAL

Source text for Eikon:  ID:nMFN14tkWf 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))